Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Second-Line Anti-Tuberculosis Agents in Healthy Volunteers
NCT02128308Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2013
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of levofloxacin, streptomycin, moxifloxacin and kanamycin in Tuberculosis (TB), sponsored by Seoul National University Hospital. Primary endpoint: Area Under the Plasma Concentration-Time Curve. Started Nov 2013; status: completed.
02
Drugs
levofloxacinstreptomycinmoxifloxacinkanamycin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02128308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02128308.